Our commitment to patients and their health is steadfast

We recognise this tremendous responsibility and also see it as an opportunity for us to improve lives and to make a lasting social impact

Our commitment

We are dedicated to promoting health and increasing access to treatment for patients. We recognise our tremendous opportunity - and responsibility - to improve lives and deliver lasting social impact.

Learn more Our commitment

Contributing to healthy communities

We contribute to healthy communities by increasing access to affordable treatments, driving science and innovation, engaging patients as well as their caregivers and healthcare professionals and advancing global health priorities

Learn more Contributing to healthy communities

Leading a responsible business

We lead a responsible business by promoting compliance, ethics and transparency, protecting the environment, improving sustainability across our supply chain, ensuring patient safety and engaging and supporting our people

Learn more Leading a responsible business

Transparency

We maintain high standards in how we promote our medicines and we're transparent in how we work

Read more

Healthy Futures Progress Report

We align our corporate resources and expertise with relevant areas of global health and social need

Read more

UK & Ireland Environmental, Social & Governance Report

We’re dedicated to promoting health and increasing access to treatment for patients, while cultivating a culture of compliance, ethics and transparency. As one of the largest suppliers of medicines to both the UK & Ireland, we take our responsibility to patients, our customers and our communities incredibly seriously.

Read more UK & Ireland Environmental, Social & Governance Report

Our responsibility

Carbon Reduction Plan

Read more

Modern Slavery Act statement

Read more

Section 172 statements

Read more

Teva Group tax policy

Read more

Prevention of corruption

Read more

Code of conduct

Read more

Gender pay reporting

Read more

Working in a regulated environment

Read more
Date of preparation: July 2024
Reference: COB-GB-NP-00039 (V6.0)